In the In a mouse model of depression, repeated Arctigenin treatment shows antidepressant- and anxiolytic-like effects via promoting the expressions of angiogenin (ANG), thrombopoietin (TPO), and vascular endothelial growth factor (VEGF) (Du et al., 2019). This evidence concerns the gene ANG and depressive symptom measurement.